Home » Daiichi Sankyo to Buy Plexxikon for Up to $935 Million
Daiichi Sankyo to Buy Plexxikon for Up to $935 Million
Daiichi Sankyo Co., Japan’s third-largest drugmaker, agreed to buy Plexxikon Inc. for as much as $935 million, accelerating its expansion into cancer medicines.
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May